Biodata Maker

Select Your Language

Notifications

webdunia
webdunia
webdunia
webdunia

Owner of Coldrif Cough Syrup Manufacturer Arrested After 21 Child Deaths in MP and Rajasthan

Advertiesment
Owner of Coldrif Cough Syrup Manufacturer Arrested After 21 Child Deaths in MP and Rajasthan

DW

, Thursday, 9 October 2025 (10:14 IST)
Police in India have arrested the owner of a pharmaceutical company that manufactures a cough syrup connected to the deaths of at least 17 children in the country.
 
Ranganathan Govindan, who runs the Tamil Nadu-based Sresan Pharmaceuticals, was taken into custody by Madhya Padhya Pradesh state police in Chennai on Wednesday night.
 
Madhya Pradesh's police had been looking for Ranganathan since at least 17 children under the age of 5 died over the last month after allegedly consuming Coldrif cough syrup made by his company.
 
India cough syrup scare
 
India's Health Ministry has said test samples of Coldrif contained diethylene glycol (DEG) —  a highly toxic industrial solvent.
 
The cough syrup was banned after a test confirmed the presence of the chemical on October 2.
 
A report by the Tamil Nadu Drugs Control Department shows that cough syrup was manufactured in unhygienic factory conditions.
 
An initial investigation has revealed that aside from Madhya Pradesh, the cough syrup was also supplied to Odisha and Puducherry, according to Indian media reports.
 
On Wednesday, Tamil Nadu Health Minister Ma Subramanian said his state's government will initiate criminal action against Sresan Pharmaceuticals.
 
Indian health authorities have also asked people to avoid Respifresh and RELIFE syrups made by companies based in Gujarat state.
 
The products have also been found to contain the same toxic chemical.
 
WHO says gaps in India's cough syrup screening
 
The World Health Organization (WHO) said on Wednesday said India had a "regulatory gap" in testing locally sold syrup medicines, Reuters news agency reported.
 
"WHO expresses deep concern over these developments and emphasizes... the regulatory gap in DEG/EG screening for domestically marketed medicines in India," Reuters cited a spokesperson of the United Nations health agency as saying.
 
The WHO said it had received confirmation from India that none of the contaminated syrups had been exported, according to Reuters.
 
However, the body urged caution as there was a possibility of some unofficial exports having taken place, the news agency added.

Share this Story:

Follow Webdunia english

Next Article

Israel, Hamas sign off on first phase of Gaza peace plan, hostage families chant 'Nobel prize to Trump'